Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer

C Rothermundt; C Hader; S Gillessen

doi:10.1093/annonc/mdv581

Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer

C Rothermundt, C Hader, S Gillessen

Division of Cancer Sciences (L5)

Kantonsspital St Gallen

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	544-5
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	27
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdv581
Publication status	Published - Mar 2016

Keywords

Angiogenesis Inhibitors/therapeutic use
Antibodies, Monoclonal, Humanized/therapeutic use
Antineoplastic Agents/therapeutic use
Axitinib
Bevacizumab/therapeutic use
Brain Edema/drug therapy
Brain Neoplasms/drug therapy
Carcinoma, Renal Cell/drug therapy
Female
Humans
Imidazoles/therapeutic use
Indazoles/therapeutic use
Lung Neoplasms/drug therapy
Middle Aged
Programmed Cell Death 1 Receptor/antagonists & inhibitors
Protein Kinase Inhibitors/therapeutic use
Pyrimidines/therapeutic use
Radiation Injuries/drug therapy
Sulfonamides/therapeutic use

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdv581

Cite this

@article{d8e3dbf38a9143b0bdec92e5dd2dfa0c,

title = "Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer",

keywords = "Angiogenesis Inhibitors/therapeutic use, Antibodies, Monoclonal, Humanized/therapeutic use, Antineoplastic Agents/therapeutic use, Axitinib, Bevacizumab/therapeutic use, Brain Edema/drug therapy, Brain Neoplasms/drug therapy, Carcinoma, Renal Cell/drug therapy, Female, Humans, Imidazoles/therapeutic use, Indazoles/therapeutic use, Lung Neoplasms/drug therapy, Middle Aged, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Protein Kinase Inhibitors/therapeutic use, Pyrimidines/therapeutic use, Radiation Injuries/drug therapy, Sulfonamides/therapeutic use",

author = "C Rothermundt and C Hader and S Gillessen",

year = "2016",

month = mar,

doi = "10.1093/annonc/mdv581",

language = "English",

volume = "27",

pages = "544--5",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer

AU - Rothermundt, C

AU - Hader, C

AU - Gillessen, S

PY - 2016/3

Y1 - 2016/3

KW - Angiogenesis Inhibitors/therapeutic use

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - Antineoplastic Agents/therapeutic use

KW - Axitinib

KW - Bevacizumab/therapeutic use

KW - Brain Edema/drug therapy

KW - Brain Neoplasms/drug therapy

KW - Carcinoma, Renal Cell/drug therapy

KW - Female

KW - Humans

KW - Imidazoles/therapeutic use

KW - Indazoles/therapeutic use

KW - Lung Neoplasms/drug therapy

KW - Middle Aged

KW - Programmed Cell Death 1 Receptor/antagonists & inhibitors

KW - Protein Kinase Inhibitors/therapeutic use

KW - Pyrimidines/therapeutic use

KW - Radiation Injuries/drug therapy

KW - Sulfonamides/therapeutic use

U2 - 10.1093/annonc/mdv581

DO - 10.1093/annonc/mdv581

M3 - Article

C2 - 26621192

SN - 0923-7534

VL - 27

SP - 544

EP - 545

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

IS - 3

ER -